T1	PROC 1 11	Evaluación
#1	AnnotatorNotes T1	C1261322; Evaluation procedure; Health Care Activity
T2	PROC 845 891	electro-foresis en gel de células individuales
T3	DISO 51 58	malaria
#2	AnnotatorNotes T3	C0024530; Malaria; Disease or Syndrome
T4	DISO 1166 1179	genotoxicidad
#3	AnnotatorNotes T4	C0598309; Genotoxicity; Cell or Molecular Dysfunction
T5	DISO 111 134	infección de la malaria
#4	AnnotatorNotes T5	C0024530; Malaria; Disease or Syndrome
T6	DISO 16 33	efecto genotóxico
#5	AnnotatorNotes T6	C0598309; Genotoxicity; Cell or Molecular Dysfunction
T7	DISO 198 214	estrés oxidativo
#6	AnnotatorNotes T7	C0242606; Oxidative Stress; Cell or Molecular Dysfunction
T8	CHEM 276 283	oxígeno
#7	AnnotatorNotes T8	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T9	DISO 311 326	daños en el ADN
#8	AnnotatorNotes T9	C0012860; DNA Damage; Cell or Molecular Dysfunction
T10	CHEM 323 326	ADN
#9	AnnotatorNotes T10	C0012854; DNA; Biologically Active Substance · Nucleic Acid, Nucleoside, or Nucleotide
T11	DISO 344 361	efecto genotóxico
#10	AnnotatorNotes T11	C0598309; Genotoxicity; Cell or Molecular Dysfunction
T12	PROC 651 662	consultaron
#11	AnnotatorNotes T12	C0009818; Consultation; Health Care Activity
T13	DISO 385 402	efecto genotóxico
#12	AnnotatorNotes T13	C0598309; Genotoxicity; Cell or Molecular Dysfunction
T14	ANAT 406 416	linfocitos
#13	AnnotatorNotes T14	C0024264; Lymphocyte; Cell
T15	DISO 457 464	malaria
#14	AnnotatorNotes T15	C0024530; Malaria; Disease or Syndrome
T16	PROC 511 544	estudio observacional transversal
#15	AnnotatorNotes T16	C1518527; Observational Study; Research Activity + C0010362; Cross-Sectional Studies; Research Activity
T17	DISO 565 572	malaria
#16	AnnotatorNotes T17	C0024530; Malaria; Disease or Syndrome
T18	DISO 620 645	infectados con Plasmodium
#17	AnnotatorNotes T18	C0024530; Malaria; Disease or Syndrome
T19	PROC 786 808	valoración transversal
#18	AnnotatorNotes T19	C0010362; Cross-Sectional Studies; Research Activity
T20	DISO 821 834	daño genético
T21	ANAT 871 878	células
#19	AnnotatorNotes T21	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T22	PROC 893 906	ensayo Cometa
#20	AnnotatorNotes T22	C0751980; Comet Assay; Molecular Biology Research Technique
T23	DISO 1137 1158	infección por malaria
#21	AnnotatorNotes T23	C0024530; Malaria; Disease or Syndrome
T24	DISO 1203 1213	tabaquismo
#22	AnnotatorNotes T24	C0040336; Tobacco Use Disorder; Mental or Behavioral Dysfunction | C0425291; Tobacco smoking consumption; Finding | C1306274; Tabagism; Mental or Behavioral Dysfunction
T25	PROC 1215 1239	tratamiento antimalárico
T26	CHEM 1227 1239	antimalárico
#23	AnnotatorNotes T26	C0003374; Antimalarials; Pharmacologic Substance
T27	LIVB 37 46	pacientes
#24	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 145 153	parásito
#25	AnnotatorNotes T28	C0030498; Parasites; Eukaryote
T29	Spec_cue 296 302	pueden
T32	LIVB 432 452	cohorte de pacientes
#27	AnnotatorNotes T32	C0599755; Cohort; Population Group + C0030705; Patients; Patient or Disabled Group
T33	LIVB 552 560	personas
#28	AnnotatorNotes T33	C0027361; Persons; Population Group
T34	LIVB 610 619	pacientes
#29	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 635 645	Plasmodium
#30	AnnotatorNotes T35	C0032148; Plasmodium <genus>; Eukaryote
T36	GENE 826 834	genético
#31	AnnotatorNotes T36	C0017337; Genes; Gene or Genome
T38	LIVB 964 973	pacientes
#32	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T40	LIVB 1109 1129	población de estudio
#33	AnnotatorNotes T40	C2348561; Study Population (group); Population Group
T41	LIVB 162 171	hospedero
#34	AnnotatorNotes T41	C1167395; Host (organism); Organism
T42	LIVB 579 588	controles
#35	AnnotatorNotes T42	C0009932; Control Groups; Group
T37	LIVB 1036 1045	controles
#36	AnnotatorNotes T37	C0009932; Control Groups; Group
A1	Assertion T9 Speculated
R1	Experiences Arg1:T27 Arg2:T6	
R2	Experiences Arg1:T27 Arg2:T3	
R3	Experiences Arg1:T27 Arg2:T1	
R4	Causes Arg1:T28 Arg2:T5	
R5	Experiences Arg1:T41 Arg2:T5	
R6	Experiences Arg1:T41 Arg2:T7	
R7	Experiences Arg1:T28 Arg2:T7	
T30	Observation 225 283	se aumenta la producción de especies reactivas del oxígeno
R8	Speculation Arg1:T29 Arg2:T9	
R10	Experiences Arg1:T41 Arg2:T9	
R11	Experiences Arg1:T41 Arg2:T30	
R12	Causes Arg1:T30 Arg2:T11	
R13	Before Arg1:T11 Arg2:T9	
R9	Causes Arg1:T30 Arg2:T7	
R14	Experiences Arg1:T28 Arg2:T30	
R15	Experiences Arg1:T28 Arg2:T9	
R16	Experiences Arg1:T28 Arg2:T11	
R17	Causes Arg1:T5 Arg2:T7	
R18	Before Arg1:T5 Arg2:T9	
R19	Causes Arg1:T5 Arg2:T11	
R20	Causes Arg1:T3 Arg2:T6	
R21	Location_of Arg1:T14 Arg2:T13	
T31	LIVB 417 424	humanos
#26	AnnotatorNotes T31	C0086418; Homo sapiens; Human
R22	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T31	
R23	Experiences Arg1:T32 Arg2:T13	
R24	Experiences Arg1:T32 Arg2:T15	
R25	Causes Arg1:T15 Arg2:T13	
R26	Experiences Arg1:T33 Arg2:T17	
T39	Quantifier_or_Qualifier 589 594	sanos
#37	AnnotatorNotes T39	C3898900; Healthy; Qualitative Concept
R27	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T39	
R28	Experiences Arg1:T34 Arg2:T18	
R29	Causes Arg1:T35 Arg2:T18	
R35	Location_of Arg1:T21 Arg2:T2	
R36	Location_of Arg1:T21 Arg2:T22	
T43	Quantifier_or_Qualifier 1046 1051	sanos
#38	AnnotatorNotes T43	C3898900; Healthy; Qualitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T43	
R40	Experiences Arg1:T40 Arg2:T23	
R41	Causes Arg1:T23 Arg2:T4	
R42	Experiences Arg1:T40 Arg2:T4	
R43	Overlap Arg1:T23 Arg2:T24	
R44	Overlap Arg1:T4 Arg2:T24	
R45	Used_for Arg1:T26 Arg2:T25	
R48	Experiences Arg1:T40 Arg2:T24	
R49	Experiences Arg1:T40 Arg2:T25	
R31	Location_of Arg1:T36 Arg2:T20	
#39	AnnotatorNotes T2	C0751980; Comet Assay; Molecular Biology Research Technique
A2	Experiencer T37 Patient
A3	Experiencer T38 Patient
A4	Experiencer T40 Patient
A5	Experiencer T27 Patient
A6	Experiencer T41 Patient
A7	Experiencer T31 Patient
A8	Experiencer T32 Patient
A9	Experiencer T33 Patient
A10	Experiencer T42 Patient
A11	Experiencer T34 Patient
